Haloperidol 10 MG Oral Tablet — RxCUI 314035
RxNorm drug concept · Semantic clinical drug
RxCUI 314035
Semantic clinical drug · SCD
● Current RxNorm concept 105 FDA products
174 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI314035
Official nameHaloperidol 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped105
Package NDCs mapped174
Reported Medicaid activity (SDUD)560,407 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Haloperidol Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The monthly injection — haloperidol decanoate — is a long-acting form designed for people with schizophrenia who are already stable on oral haloperidol. The idea is to give you ste...
- Why am I getting a monthly injection instead of just taking a pill every day?
- The most common side effects involve movement — things like muscle stiffness, slow movement, tremor, or a restless urge to keep moving. These are worth mentioning to your doctor, b...
- What side effects should I expect, and which ones mean I need to call someone right away?
🕸️ Concept Web — How Haloperidol 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Haloperidol 10 MG Oral Tablet
RxCUI 314035 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Haloperidol
5093IN
-
Haloperidol
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Haloperidol Oral Tablet
372377SCDF -
Haloperidol Oral Product
1160300SCDG -
Haloperidol Pill
1160301SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Haloperidol Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Haloperidol 10 MG
316026SCDC
-
Haloperidol 10 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Haloperidol 10 MG
SCDC · 316026 -
Haloperidol Oral Tablet
SCDF · 372377 -
Haloperidol Oral Product
SCDG · 1160300 -
Haloperidol Pill
SCDG · 1160301
📦 FDA Products & Package NDCs
105 products · 174 package NDCs
174 package NDCs map to RxCUI 314035 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 58657-0702-01 | 100 TABLET in 1 BOTTLE (58657-702-01) | Haloperidol | Method Pharmaceuticals, LLC | 2019-11-25 |
| 58657-0703-01 | 100 TABLET in 1 BOTTLE (58657-703-01) | Haloperidol | Method Pharmaceuticals, LLC | 2019-11-25 |
| 58657-0703-10 | 1000 TABLET in 1 BOTTLE (58657-703-10) | Haloperidol | Method Pharmaceuticals, LLC | 2019-11-25 |
| 58657-0704-01 | 100 TABLET in 1 BOTTLE (58657-704-01) | Haloperidol | Method Pharmaceuticals, LLC | 2019-11-25 |
| 58657-0705-01 | 100 TABLET in 1 BOTTLE (58657-705-01) | Haloperidol | Method Pharmaceuticals, LLC | 2019-11-25 |
| 58657-0900-01 | 100 TABLET in 1 CARTON (58657-900-01) | Haloperidol | Method Pharmaceuticals, LLC | 2025-06-05 |
| 58657-0901-01 | 100 TABLET in 1 CARTON (58657-901-01) | Haloperidol | Method Pharmaceuticals, LLC | 2025-06-05 |
| 58657-0902-01 | 100 TABLET in 1 CARTON (58657-902-01) | Haloperidol | Method Pharmaceuticals, LLC | 2025-06-05 |
| 58657-0903-01 | 100 TABLET in 1 CARTON (58657-903-01) | Haloperidol | Method Pharmaceuticals, LLC | 2025-06-05 |
| 58657-0904-01 | 100 TABLET in 1 CARTON (58657-904-01) | Haloperidol | Method Pharmaceuticals, LLC | 2025-06-05 |
| 58657-0905-01 | 100 TABLET in 1 CARTON (58657-905-01) | Haloperidol | Method Pharmaceuticals, LLC | 2025-06-05 |
| 58657-0905-03 | 30 TABLET in 1 CARTON (58657-905-03) | Haloperidol | Method Pharmaceuticals, LLC | 2025-06-05 |
| 59651-0789-01 | 100 TABLET in 1 BOTTLE (59651-789-01) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0789-99 | 1000 TABLET in 1 BOTTLE (59651-789-99) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0790-01 | 100 TABLET in 1 BOTTLE (59651-790-01) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0790-99 | 1000 TABLET in 1 BOTTLE (59651-790-99) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0791-01 | 100 TABLET in 1 BOTTLE (59651-791-01) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0791-99 | 1000 TABLET in 1 BOTTLE (59651-791-99) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0792-01 | 100 TABLET in 1 BOTTLE (59651-792-01) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0792-99 | 1000 TABLET in 1 BOTTLE (59651-792-99) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0793-01 | 100 TABLET in 1 BOTTLE (59651-793-01) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0793-99 | 1000 TABLET in 1 BOTTLE (59651-793-99) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0794-01 | 100 TABLET in 1 BOTTLE (59651-794-01) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 59651-0794-99 | 1000 TABLET in 1 BOTTLE (59651-794-99) | Haloperidol | Aurobindo Pharma Limited | 2024-04-19 |
| 63629-2326-01 | 100 TABLET in 1 BOTTLE (63629-2326-1) | Haloperidol | Bryant Ranch Prepack | 2021-02-17 |
| 65841-0626-01 | 100 TABLET in 1 BOTTLE (65841-626-01) | Haloperidol | Zydus Lifesciences Limited | 2008-01-03 |
| 65841-0626-10 | 1000 TABLET in 1 BOTTLE (65841-626-10) | Haloperidol | Zydus Lifesciences Limited | 2008-01-03 |
| 65841-0627-01 | 100 TABLET in 1 BOTTLE (65841-627-01) | Haloperidol | Zydus Lifesciences Limited | 2008-01-03 |
| 65841-0627-10 | 1000 TABLET in 1 BOTTLE (65841-627-10) | Haloperidol | Zydus Lifesciences Limited | 2008-01-03 |
| 65841-0628-01 | 100 TABLET in 1 BOTTLE (65841-628-01) | Haloperidol | Zydus Lifesciences Limited | 2008-01-03 |
| 65841-0628-06 | 30 TABLET in 1 BOTTLE (65841-628-06) | Haloperidol | Zydus Lifesciences Limited | 2008-01-03 |
| 65841-0837-01 | 100 TABLET in 1 BOTTLE (65841-837-01) | Haloperidol | Zydus Lifesciences Limited | 2023-02-01 |
| 65841-0837-10 | 1000 TABLET in 1 BOTTLE (65841-837-10) | Haloperidol | Zydus Lifesciences Limited | 2023-02-01 |
| 65841-0837-77 | 10 BLISTER PACK in 1 CARTON (65841-837-77) / 10 TABLET in 1... | Haloperidol | Zydus Lifesciences Limited | 2023-02-01 |
| 65841-0838-01 | 100 TABLET in 1 BOTTLE (65841-838-01) | Haloperidol | Zydus Lifesciences Limited | 2023-02-01 |
| 65841-0838-10 | 1000 TABLET in 1 BOTTLE (65841-838-10) | Haloperidol | Zydus Lifesciences Limited | 2023-02-01 |
| 65841-0838-77 | 10 BLISTER PACK in 1 CARTON (65841-838-77) / 10 TABLET in 1... | Haloperidol | Zydus Lifesciences Limited | 2023-02-01 |
| 65841-0839-01 | 100 TABLET in 1 BOTTLE (65841-839-01) | Haloperidol | Zydus Lifesciences Limited | 2023-02-01 |
| 65841-0839-10 | 1000 TABLET in 1 BOTTLE (65841-839-10) | Haloperidol | Zydus Lifesciences Limited | 2023-02-01 |
| 65841-0839-77 | 10 BLISTER PACK in 1 CARTON (65841-839-77) / 10 TABLET in 1... | Haloperidol | Zydus Lifesciences Limited | 2023-02-01 |
| 67046-0838-03 | 30 TABLET in 1 BLISTER PACK (67046-0838-3) | Haloperidol | Coupler LLC | 2026-04-29 |
| 68084-0249-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-249-01) / 1 TAB... | Haloperidol | American Health Packaging | 2008-03-03 |
| 68084-0250-21 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-250-21) / 1 TABL... | Haloperidol | American Health Packaging | 2008-04-04 |
| 68382-0079-01 | 100 TABLET in 1 BOTTLE (68382-079-01) | Haloperidol | Zydus Pharmaceuticals USA Inc. | 2008-01-03 |
| 68382-0079-10 | 1000 TABLET in 1 BOTTLE (68382-079-10) | Haloperidol | Zydus Pharmaceuticals USA Inc. | 2008-01-03 |
| 68382-0080-01 | 100 TABLET in 1 BOTTLE (68382-080-01) | Haloperidol | Zydus Pharmaceuticals USA Inc. | 2008-01-03 |
| 68382-0080-06 | 30 TABLET in 1 BOTTLE (68382-080-06) | Haloperidol | Zydus Pharmaceuticals USA Inc. | 2008-01-03 |
| 68382-0080-10 | 1000 TABLET in 1 BOTTLE (68382-080-10) | Haloperidol | Zydus Pharmaceuticals USA Inc. | 2008-01-03 |
| 68382-0081-01 | 100 TABLET in 1 BOTTLE (68382-081-01) | Haloperidol | Zydus Pharmaceuticals USA Inc. | 2008-01-03 |
| 68382-0081-06 | 30 TABLET in 1 BOTTLE (68382-081-06) | Haloperidol | Zydus Pharmaceuticals USA Inc. | 2008-01-03 |
Observed labelers:
Zydus Pharmaceuticals USA Inc. (16) ·
Zydus Lifesciences Limited (15) ·
Creekwood Pharmaceuticals LLC (14) ·
Method Pharmaceuticals, LLC (14) ·
AiPing Pharmaceutical, Inc (12) ·
Aurobindo Pharma Limited (12)
· +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.